CURE vs. QLD
Compare and contrast key facts about Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra QQQ (QLD).
CURE and QLD are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. QLD is a passively managed fund by ProShares that tracks the performance of the NASDAQ-100 Index (200%). It was launched on Jun 21, 2006. Both CURE and QLD are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CURE or QLD.
Correlation
The correlation between CURE and QLD is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CURE vs. QLD - Performance Comparison
Key characteristics
CURE:
-0.43
QLD:
0.11
CURE:
-0.39
QLD:
0.41
CURE:
0.95
QLD:
1.05
CURE:
-0.40
QLD:
0.17
CURE:
-0.88
QLD:
0.41
CURE:
17.26%
QLD:
10.79%
CURE:
35.31%
QLD:
39.23%
CURE:
-69.19%
QLD:
-83.13%
CURE:
-27.71%
QLD:
-23.77%
Returns By Period
In the year-to-date period, CURE achieves a 11.61% return, which is significantly higher than QLD's -15.36% return. Over the past 10 years, CURE has underperformed QLD with an annualized return of 11.82%, while QLD has yielded a comparatively higher 26.72% annualized return.
CURE
11.61%
-10.63%
-20.87%
-10.97%
23.66%
11.82%
QLD
-15.36%
-9.10%
-6.64%
6.35%
34.99%
26.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CURE vs. QLD - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than QLD's 0.95% expense ratio.
Risk-Adjusted Performance
CURE vs. QLD — Risk-Adjusted Performance Rank
CURE
QLD
CURE vs. QLD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra QQQ (QLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CURE vs. QLD - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.04%, more than QLD's 0.27% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.04% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% | 0.00% |
QLD ProShares Ultra QQQ | 0.27% | 0.25% | 0.33% | 0.31% | 0.00% | 0.00% | 0.13% | 0.06% | 0.02% | 0.90% | 0.11% | 0.19% |
Drawdowns
CURE vs. QLD - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum QLD drawdown of -83.13%. Use the drawdown chart below to compare losses from any high point for CURE and QLD. For additional features, visit the drawdowns tool.
Volatility
CURE vs. QLD - Volatility Comparison
The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 11.48%, while ProShares Ultra QQQ (QLD) has a volatility of 15.49%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than QLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.